EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout

Seong-Kyu Kim iD

Journal of Rheumatic Diseases · 01.07.2022 · 29 (3) · 140-153

DOI: 10.4078/jrd.2022.29.3.140 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Rheumatic Diseases, erschienen am 01.07.2022. Verfasst von Seong-Kyu Kim. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NACHT, LRR, and PYD-domains-containing protein 3 (NLRP3) inflammasome is an intracellular multi-protein signaling platform that is activated by cytosolic pattern-recognition receptors such as NLRs against endogenous and exogenous pathogens. Once it is activated by a variety of danger signals, recruitment and assembly of NLRP3, ASC, and pro-caspase-1 trigger the processing and release of pro-inflammatory cytokines including interleukin-1β (IL-1β) and IL-18. Multiple intracellular and extracellular structures and molecular mechanisms are involved in NLRP3 inflammasome activation. Gout is an autoinflammatory disease induced by inflammatory response through production of NLRP3 inflammasome-mediated proinflammatory cytokines such as IL-1β by deposition of monosodium urate (MSU) crystals in the articular joints and periarticular structures. NLRP3 inflammasome is considered a main therapeutic target in MSU crystal-induced inflammation in gout. Novel therapeutic strategies have been proposed to control acute flares of gouty arthritis and prophylaxis for gout flares through modulation of the NLRP3/IL-1 axis pathway. This review discusses the basic mechanism of NLRP3 inflammasome activation and the IL-1-induced inflammatory cascade and explains the NLRP3 inflammasome-induced pathogenic role in the pathogenesis of gout.

Schlagwörter

Stichwörter der Autor:innen

GoutInflammasomeInterleukin-1Monosodium urateNLRP3

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.

ORCID-Profile: Seong-Kyu Kim

Zitieren

APA

Kim, S. K. (2022). The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout. Journal of Rheumatic Diseases, 29(3), 140-153. https://doi.org/10.4078/jrd.2022.29.3.140

Vancouver

Kim SK. The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout. Journal of Rheumatic Diseases. 2022;29(3):140-153. doi:10.4078/jrd.2022.29.3.140

BibTeX
@article{Kim2022,
  author = {Kim, Seong-Kyu},
  title = {The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout},
  journal = {Journal of Rheumatic Diseases},
  year = {2022},
  volume = {29},
  number = {3},
  pages = {140--153},
  doi = {10.4078/jrd.2022.29.3.140}
}
Kostenlos starten →